![Logo for Syros Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8471f-2023-03-01-10-59-38.png&w=256&q=100)
Syros Pharmaceuticals Investor Relations Material
Latest events
![Logo for Syros Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8471f-2023-03-01-10-59-38.png&w=128&q=100)
Q2 2024
Syros Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Syros Pharmaceuticals Inc
Access all reports
Syros Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. With its proprietary platform technology, Syros is developing an innovative pipeline of small molecule drugs designed to act at the level of the genome to promote cell survival, block disease activity and restore healthy homeostasis in patients.The company have indentified several drug targets in cancer and metabolic diseases, including disease-causing genes methyltransferases and histone acetyltransferases (HATs), as well as drivers of master oncogenic pathways such as PI3K and MEK.
Key slides for Syros Pharmaceuticals Inc
![MDS Epidemiology
O](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fsyros-pharmaceuticals-inc-status-update-5529d440cd65bddb%2F15.png&w=3840&q=75)
![Logo for Syros Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8471f-2023-03-01-10-59-38.png&w=128&q=100)
Status Update
Syros Pharmaceuticals Inc
![•
•
•
Here's w](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fsyros-pharmaceuticals-inc-status-update-5529d440cd65bddb%2F4.png&w=3840&q=75)
![Logo for Syros Pharmaceuticals Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8471f-2023-03-01-10-59-38.png&w=128&q=100)
Status Update
Syros Pharmaceuticals Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
SYRS
Country
🇺🇸 United States